News
-
-
-
COMMUNIQUÉ DE PRESSE
Original-Research: Vidac Pharma Holding Plc (von Sphene Capital GmbH): Buy
Research analysis reveals the effectiveness of mitochondrial transplantation in increasing tumour cell sensitivity to chemotherapy, confirming Vidac Pharma's innovative approach. Buy recommendation maintained for Vidac Pharma -
COMMUNIQUÉ DE PRESSE
5E Advanced Materials Announces Pricing of $8.31 Million Public Offering of Common Stock
5E Advanced Materials, Inc. announces pricing of underwritten public offering of common stock in the United States to raise approximately $8.31 million. Offering expected to close on August 25, 2025 -
-
-
-
COMMUNIQUÉ DE PRESSE
Total du nombre de droits de vote et du capital / Information relative au nombre total de droits de vote et d'actions composant le capital
Communiqué de presse concernant le nombre total de droits de vote et d'actions d'ABIONYX Pharma. Détails sur le capital social et les droits de vote bruts et nets -
COMMUNIQUÉ DE PRESSE
Total number of voting rights and capital / Information on the total number of voting rights and the number of shares making up the capital
ABIONYX Pharma discloses monthly statement of total voting rights and shares on Euronext Paris. Company focused on innovative medicines in rare diseases -
COMMUNIQUÉ DE PRESSE
Pegasus Resources Announces Close of Non-Brokered Private Placement
Pegasus Resources Inc. closes non-brokered private placement, raising $250,080.00. Proceeds to be used for working capital. Insiders participated in the Offering. Company focused on uranium exploration in the United States
